Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
John Bardeen
Late relapse of germ cell tumors (GCTs) following prior chemotherapy or surgery-only treatment refers to the recurrence of GCTs after an initial period of remission. This phenomenon poses a challenge in the management and long-term follow-up of patients with GCTs. The aim of this study was to investigate the clinical characteristics, treatment outcomes, and prognostic factors associated with late relapse in GCT patients who had previously received chemotherapy or surgery-only treatment. A comprehensive review of medical records was conducted to identify patients who experienced late relapse. The key findings of this study highlight the importance of long-term surveillance and close monitoring of GCT patients even after apparent remission. Additionally, the study identified several potential prognostic factors that may aid in the identification of patients at higher risk of late relapse, facilitating early detection and intervention.